← Back to Search

Collagen Dressing

Collagen wound dressing with positive and negative controls for Allergic Contact Dermatitis

N/A

Waitlist Available

Led By Jordan DeSantis, MHI, BS

Research Sponsored by Covalon Technologies Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age: 18-70

Individuals free of any dermatological or systemic disorder that could interfere with study results

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 48 hours post-induction #1

Awards & highlights

Study Summary

This trial aims to test how irritating and potentially allergy-inducing a specific type of wound dressing is when applied repeatedly to the skin.

Who is the study for?

This trial is for individuals who may have allergic contact dermatitis and are interested in testing a new dressing called ColActive Plus Collagen Matrix Dressing. Specific eligibility criteria were not provided, so it's best to consult the study team for details on who can participate.Check my eligibility

What is being tested?

The trial is designed to assess the irritation and potential for causing allergies of a collagen-based wound dressing when applied repeatedly under controlled conditions.See study design

What are the potential side effects?

Potential side effects might include skin irritation or an allergic reaction at the site where the dressing is applied, but specific side effects will be determined during the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 70 years old.

Select...

I don't have skin or body-wide diseases that could affect the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 48 hours post-induction #1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~48 hours post-induction #1

This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 hours post-induction #1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Skin irritation reaction using Berger and Bowman scale

Other outcome measures

Skin sensitization reaction using Berger and Bowman scale

Trial Design

1Treatment groups

Experimental Treatment

Group I: Collagen wound dressing with positive and negative controlsExperimental Treatment1 Intervention

Application of test dressing, 0.5% sodium lauryl sulfate in distilled water, and distilled water on areas of the back or upper arm.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

ColActive Plus Collagen Matrix Dressing

2024

N/A

~60

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Covalon Technologies Inc.Lead Sponsor

3 Previous Clinical Trials

283 Total Patients Enrolled

ALS Beauty and Personal CareUNKNOWN

2 Previous Clinical Trials

131 Total Patients Enrolled

Jordan DeSantis, MHI, BSPrincipal InvestigatorALS

1 Previous Clinical Trials

30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to participate in this research study?

"To be eligible for enrollment in this research study, individuals must present with allergic contact dermatitis and fall within the age range of 18 to 70 years. A total of 75 participants will be accepted into the trial."

Answered by AI

Is the enrollment for this research study currently open?

"Information on clinicaltrials.gov confirms that this trial is actively seeking volunteers. It was initially made available on January 31st, 2024, and its last modification was recorded on February 22nd of the same year."

Answered by AI

Can individuals who have surpassed the age of 75 partake in this study?

"Enrollment is open for individuals aged 18 to below 70 years old."

Answered by AI

What is the total number of participants involved in this clinical research study?

"Yes, data from clinicaltrials.gov indicates that this investigation is actively pursuing participants. The trial was first made public on January 31st, 2024 and last revised on February 22nd, 2024. Recruitment aims to enroll a total of 75 individuals at one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HRIPT for Collagen Dressing

2024. "HRIPT for Collagen Dressing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06283173.

All > Anaheim > Paid Studies Ventura